Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications

NCT04846959 · clinicaltrials.gov ↗

RECRUITING

Status

818

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment

Interventions

DRUG: Risankizumab
DRUG: Comparator

Sponsor

AbbVie

Collaborators

[object Object]